These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8784659

  • 21. Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
    Kumar TC, Khanna S.
    Aust N Z J Psychiatry; 2000 Jun; 34(3):527-8. PubMed ID: 10881981
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 23. Inability to cry during SRI treatment.
    Oleshansky MA, Labbate LA.
    J Clin Psychiatry; 1996 Dec; 57(12):593. PubMed ID: 9010124
    [No Abstract] [Full Text] [Related]

  • 24. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [Abstract] [Full Text] [Related]

  • 25. Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
    Fineberg NA, Bullock T, Montgomery DB, Montgomery SA.
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():43-7. PubMed ID: 1517558
    [No Abstract] [Full Text] [Related]

  • 26. Panic attacks precipitated by sertraline.
    Zinner SH.
    Am J Psychiatry; 1994 Jan; 151(1):147-8. PubMed ID: 8267115
    [No Abstract] [Full Text] [Related]

  • 27. Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants?
    Gupta MA, Gupta AK.
    Cutis; 1995 Jul; 56(1):53-4. PubMed ID: 7555104
    [Abstract] [Full Text] [Related]

  • 28. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
    Lydiard RB.
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
    [Abstract] [Full Text] [Related]

  • 29. Medication optimization during clozapine treatment.
    Suppes T, Rush AJ.
    J Clin Psychiatry; 1996 Jul; 57(7):307-8. PubMed ID: 8666574
    [No Abstract] [Full Text] [Related]

  • 30. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Todorov C, Freeston MH, Borgeat F.
    Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
    [Abstract] [Full Text] [Related]

  • 31. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L.
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [Abstract] [Full Text] [Related]

  • 32. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G, Albert U, Salvi V, Bogetto F.
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [Abstract] [Full Text] [Related]

  • 33. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ, Saiz J, Cottraux J, Note I, Viñas R, Bourgeois M, Hernández M, Gómez-Pérez JC.
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [Abstract] [Full Text] [Related]

  • 34. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA, Seay SM.
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [Abstract] [Full Text] [Related]

  • 35. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
    Zarate CA, Kando JC, Tohen M, Weiss MK, Cole JO.
    J Clin Psychiatry; 1996 Feb; 57(2):67-71. PubMed ID: 8591971
    [Abstract] [Full Text] [Related]

  • 36. Sertraline: a new antidepressant.
    Auster R.
    Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
    [Abstract] [Full Text] [Related]

  • 37. Fluoxetine versus phenelzine in obsessive-compulsive disorder.
    Golwyn DH, Sevlie CP.
    Am J Psychiatry; 1999 Jan; 156(1):159-60. PubMed ID: 9892321
    [No Abstract] [Full Text] [Related]

  • 38. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
    Murdoch D, McTavish D.
    Drugs; 1992 Oct; 44(4):604-24. PubMed ID: 1281075
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
    Kim SC, Seo KK.
    J Urol; 1998 Feb; 159(2):425-7. PubMed ID: 9649255
    [Abstract] [Full Text] [Related]

  • 40. The Pharmacological Treatment of Obsessive-Compulsive Disorder.
    Pittenger C.
    Psychiatr Clin North Am; 2023 Mar; 46(1):107-119. PubMed ID: 36740347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.